Microsatellite Stable Metastatic Colorectal Cancer

Oncology

Prevalence

135.0 / 100K

Incidence

36.0 / 100K/yr

2 drugs in development·1 company·1 clinical trial

Drug Pipeline by Phase

Compare drugs

Frequently asked questions

How many drugs are in development for Microsatellite Stable Metastatic Colorectal Cancer?

BioSniper tracks 2 drugs in development for Microsatellite Stable Metastatic Colorectal Cancer across 1 company.

How many clinical trials target Microsatellite Stable Metastatic Colorectal Cancer?

There are 1 clinical trial targeting Microsatellite Stable Metastatic Colorectal Cancer tracked by BioSniper.

What is the prevalence of Microsatellite Stable Metastatic Colorectal Cancer?

The estimated prevalence of Microsatellite Stable Metastatic Colorectal Cancer is approximately 135.0 per 100,000 population.

Deep-dive into Microsatellite Stable Metastatic Colorectal Cancer

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    Microsatellite Stable Metastatic Colorectal Cancer — Drugs in Development & Clinical Trials | BioSniper